Global Apheresis Equipment Market Size Likely to Surpass at a CAGR of 12.2% By 2033

As per the current market research conducted by the CMI Team, the global Apheresis Equipment Market size is expected to record a CAGR of 12.2% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 4,673.2 Million. By 2033, the valuation is anticipated to reach USD 13,169.1 Million.

Apheresis Equipment Market: Growth Factors and Dynamics

• Increasing Prevalence of Chronic Diseases: The rising incidence of chronic diseases such as cancer, autoimmune disorders, and renal diseases is driving the demand for apheresis equipment. These conditions often require therapeutic apheresis procedures to manage symptoms and improve patient outcomes.

• Technological Advancements: Continuous innovation in apheresis equipment, including improvements in device efficiency, safety, and automation, is fostering market growth. Advanced technologies are enhancing the precision and effectiveness of therapeutic procedures, attracting healthcare providers and patients alike.

• Growing Aging Population: The aging population is more susceptible to chronic diseases and conditions that necessitate apheresis treatments. As the elderly demographic expands globally, there is an increasing need for therapeutic interventions like apheresis to manage age-related health challenges.

• Expansion of Indications for Apheresis: Apheresis is increasingly being used in a broader range of medical conditions beyond traditional applications. This includes neurological disorders, cardiovascular diseases, and hematological disorders, thereby widening the market scope and driving adoption.

• Rising Demand for Blood Components: Blood donation centers and hospitals are experiencing growing demand for specific blood components like platelets, plasma, and red blood cells. Apheresis equipment plays a critical role in efficiently collecting these components, meeting the demand for transfusion and therapeutic purposes.

• Supportive Healthcare Policies and Reimbursement: Favorable healthcare policies and reimbursement frameworks support the adoption of apheresis procedures. Governments and insurance providers are increasingly recognizing the clinical benefits of apheresis, which encourages healthcare facilities to invest in advanced equipment and offer these services to patients.

• Increasing Awareness and Education: There is a growing emphasis on raising awareness about the benefits of apheresis therapies among healthcare professionals and patients. Educational initiatives and training programs are helping to expand the knowledge base and skillset required for performing apheresis procedures effectively, thereby contributing to market growth by enhancing confidence in the technology and its applications.

Apheresis Equipment Market: Partnership and Acquisitions

• In 2023, TERUMO BCT, INC. participated in the second instalment of the Connecting the Dot series, a film series designed for European MedTech companies. This participation underscores their commitment to fostering collaboration and innovation within the industry through knowledge sharing and networking opportunities.

• In 2021, Fresenius Kabi AG, a pharmaceutical company, inaugurated a USD 32.2 million expansion of its transfusion and apheresis disposables plant in the Dominican Republic. This expansion enhances the company’s global export capabilities for apheresis and plasma collection sets, reinforcing its market position.

Report Scope

Apheresis Equipment Market: COVID-19 Analysis

The COVID-19 pandemic has significantly impacted the Apheresis Equipment Market, with the industry experiencing both positive and negative effects. Here are some of the key impacts:

• Disruption in Routine Medical Procedures: The COVID-19 pandemic led to disruptions in elective medical procedures, including apheresis treatments, as healthcare facilities prioritized resources for pandemic response. This resulted in reduced procedural volumes and revenue loss for apheresis equipment providers.

• Supply Chain Disruptions: Global supply chain disruptions caused delays in the manufacturing and distribution of apheresis equipment and consumables. Shortages of critical components and raw materials further exacerbated challenges in meeting demand during the pandemic.

• Resumption of Elective Procedures: As COVID-19 cases decline and healthcare systems stabilize, there is a gradual resumption of elective procedures, including apheresis treatments. This recovery phase helps restore procedural volumes and revenue streams for apheresis equipment manufacturers.

• Adoption of Telemedicine and Remote Monitoring: The adoption of telemedicine and remote monitoring solutions has facilitated the continuity of care for patients requiring apheresis treatments. Virtual consultations and remote monitoring of patients have minimized disruptions and enhanced patient management efficiency.

• Focus on Safety Protocols and Infection Control Measures: Enhanced safety protocols and infection control measures in healthcare settings have boosted patient confidence in undergoing apheresis procedures. Strict adherence to guidelines mitigates health risks associated with COVID-19 and other infections, supporting market recovery.

• Government Support and Healthcare Policies: Governments and healthcare authorities have implemented supportive policies and funding initiatives to mitigate the impact of COVID-19 on healthcare services, including apheresis treatments. Financial aid and regulatory flexibility have facilitated operational continuity and market rebound.

• Innovation and Technological Advancements: Continued innovation in apheresis equipment, such as improvements in automation, efficiency, and safety features, has spurred market recovery. Advanced technologies enhance procedural outcomes and operational efficiency, driving demand and adoption post-pandemic.

• Collaboration and Partnerships: Collaborative efforts between healthcare providers, equipment manufacturers, and research institutions have facilitated knowledge sharing, resource pooling, and the development of resilient strategies to navigate and recover from the impact of COVID-19 on the apheresis equipment market. Such partnerships strengthen the industry’s response capabilities and contribute to sustained market recovery.

In conclusion, the COVID-19 pandemic has had a mixed impact on the Apheresis Equipment Market, with some challenges and opportunities arising from the pandemic.

List of the prominent players in the Apheresis Equipment Market:

• Terumo BCT Inc.
• Fresenius SE & Co. KGaA
• Haemonetics Corporation
• Asahi Kasei Medical Co. Ltd.
• Baxter International Inc.
• Kaneka Corporation
• Braun Melsungen AG
• Nikkiso Co. Ltd.
• Medica S.p.A.
• Miltenyi Biotec
• Thermo Fisher Scientific Inc.
• Hemonetics Corporation
• Cerus Corporation
• MacoPharma
• Gambro
• Others

The Apheresis Equipment Market is segmented as follows:

By Product Type

• Plasmapheresis Equipment
• Photopheresis Equipment
• LDL Apheresis Equipment
• Others

By Technology

• Centrifugation Apheresis
• Membrane Filtration Apheresis

By Application

• Renal Disease
• Neurology
• Hematology
• Others

By End User

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Blood Donation Centers
• Others

Regional Coverage:

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Russia
• Italy
• Spain
• Netherlands
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Taiwan
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America